'Striking' findings could change asthma therapy

Study may impact how GPs manage mild cases: experts

Advice for managing mild asthma in adults could change after a study showed combination preventer-reliever inhalers prevent more severe exacerbations than usual maintenance therapy.

Asthma reliever

In the 52-week, open-label trial, those patients asked to use combi­nation budesonide-formoterol (Symbicort) as needed had 56% fewer severe exacerbations than those asked to use twice-daily budesonide, plus salbutamol as needed.

“It’s a striking study and certainly has implications for people who don’t have a lot of symptoms,” said GP Professor